US Patent Litigations are now available. Check here

Explore Actelion Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3897646May 22, 2024Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension3
EP3256125Jan 26, 2022Dosing Regimen For A Selective S1P1 Receptor Agonist2
EP3592391Apr 21, 2021Pharmaceutical Composition Comprising Selexipag1
EP3300729Oct 9, 2019Therapeutic Compositions Containing Macitentan3
EP2315587Oct 25, 2017Therapeutic Compositions Containing Macitentan5